Experiment summary for ENCSR959LTT

doi:10.17989/ENCSR959LTT

Summary

Status
released
Assay
RNA-seq (total RNA-seq)
Biosample summary
Homo sapiens foreskin keratinocyte male newborn (2-4 days) treated with 1.2 mM calcium for 2.5 days
Biosample Type
primary cell
Replication type
anisogenic
Description
RiboZero RNA-seq on primary keratinocytes in day 3 of differentiation
Treatments
1.2 mM calcium (CHEBI:86158) for 2.5 days
Nucleic acid type
RNA
RNA integrity number
8.5 [2-1]9 [1-1]
Depleted in
rRNA
Size range
>200
Extraction method
Qiagen RNA extraction
Strand specificity
Strand-specific (reverse)

Attribution

Genomics of Gene Regulation Project
Lab
Michael Snyder, Stanford
Award
U01HG007919 (Michael Snyder, Stanford)
Project
GGR
External resources
Aliases
michael-snyder:ggr-skin-rnaseq-ribozero-day3
Date submitted
December 9, 2016
Date released
October 10, 2017
Treatment Time Series
ENCSR008KOR 

Anisogenic replicates

Anisogenic replicate
Technical replicate
Summary
Biosample
Library
21Homo sapiens male newborn (2-4 days) foreskin keratinocyte primary cell treated with 1.2 mM calcium for 2.5 daysENCBS299ONKENCLB807NTL
11Homo sapiens male newborn (2-4 days) foreskin keratinocyte primary cell treated with 1.2 mM calcium for 2.5 daysENCBS079LRUENCLB291OIW